226 related articles for article (PubMed ID: 9404561)
1. Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5-induced eosinophil degranulation and prolonged survival.
Meng Q; Ying S; Corrigan CJ; Wakelin M; Assoufi B; Moqbel R; Kay AB
Allergy; 1997 Nov; 52(11):1095-101. PubMed ID: 9404561
[TBL] [Abstract][Full Text] [Related]
2. The influence of IL-3, IL-5, and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation.
Carlson M; Peterson C; Venge P
Allergy; 1993 Aug; 48(6):437-42. PubMed ID: 8238799
[TBL] [Abstract][Full Text] [Related]
3. Release of granule proteins from eosinophils cultured with IL-5.
Kita H; Weiler DA; Abu-Ghazaleh R; Sanderson CJ; Gleich GJ
J Immunol; 1992 Jul; 149(2):629-35. PubMed ID: 1624806
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the release of eosinophil cationic protein by eosinophil adhesion.
Xu X; Håkansson L
Clin Exp Allergy; 2000 Jun; 30(6):794-806. PubMed ID: 10848898
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of transforming growth factor beta 1 on cytokine-enhanced eosinophil survival and degranulation.
Atsuta J; Fujisawa T; Iguchi K; Terada A; Kamiya H; Sakurai M
Int Arch Allergy Immunol; 1995; 108 Suppl 1():31-5. PubMed ID: 7549518
[TBL] [Abstract][Full Text] [Related]
6. Eosinophil granulocyte interaction with serum-opsonized particles: binding and degranulation are enhanced by tumor necrosis factor alpha.
Egesten A; Blom M; Calafat J; Janssen H; Knol EF
Int Arch Allergy Immunol; 1998 Feb; 115(2):121-8. PubMed ID: 9482700
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoids inhibit cytokine-mediated eosinophil survival.
Wallen N; Kita H; Weiler D; Gleich GJ
J Immunol; 1991 Nov; 147(10):3490-5. PubMed ID: 1940348
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone inhibits prolonged survival and autocrine granulocyte-macrophage colony-stimulating factor production by human eosinophils cultured on laminin or tissue fibronectin.
Walsh GM; Wardlaw AJ
J Allergy Clin Immunol; 1997 Aug; 100(2):208-15. PubMed ID: 9275142
[TBL] [Abstract][Full Text] [Related]
9. Effects of interleukin (IL)-3 and IL-5 on human eosinophil degranulation induced by complement components C3a and C5a.
Takafuji S; Tadokoro K; Ito K
Allergy; 1996 Aug; 51(8):563-8. PubMed ID: 8874660
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms for eosinophil degranulation; release of the eosinophil cationic protein.
Winqvist I; Olofsson T; Olsson I
Immunology; 1984 Jan; 51(1):1-8. PubMed ID: 6317543
[TBL] [Abstract][Full Text] [Related]
11. The effect of recombinant human interleukin-5 on eosinophil accumulation and degranulation in human nasal mucosa.
Terada N; Konno A; Tada H; Shirotori K; Ishikawa K; Togawa K
J Allergy Clin Immunol; 1992 Aug; 90(2):160-8. PubMed ID: 1500623
[TBL] [Abstract][Full Text] [Related]
12. Phorbol ester-induced degranulation in adherent human eosinophil granulocytes is dependent on CD11/CD18 leukocyte integrins.
Egesten A; Gullberg U; Olsson I; Richter J
J Leukoc Biol; 1993 Mar; 53(3):287-93. PubMed ID: 8095965
[TBL] [Abstract][Full Text] [Related]
13. IL-5 as a strong secretagogue for human eosinophils.
Fujisawa T; Terada A; Atsuta J; Iguchi K; Kamiya H; Sakurai M
Int Arch Allergy Immunol; 1997 Oct; 114 Suppl 1():81-3. PubMed ID: 9363934
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of theophylline and procaterol on interleukin-5-induced degranulation from human eosinophils.
Fujisawa T; Kato Y; Terada A; Iguchi K; Kamiya H
J Asthma; 2002 Feb; 39(1):21-7. PubMed ID: 11883736
[TBL] [Abstract][Full Text] [Related]
15. Release of granule proteins from human eosinophils stimulated with mast-cell mediators.
Takafuji S; Tadokoro K; Ito K; Nakagawa T
Allergy; 1998 Oct; 53(10):951-6. PubMed ID: 9821474
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of interleukin-5 mediated eosinophil viability by fluticasone 17-propionate: comparison with other glucocorticoids.
Hagan JB; Kita H; Gleich GJ
Clin Exp Allergy; 1998 Aug; 28(8):999-1006. PubMed ID: 9756205
[TBL] [Abstract][Full Text] [Related]
17. Eosinophil degranulation in the presence of bronchial epithelial cells. Effect of cytokines and role of adhesion.
Takafuji S; Ohtoshi T; Takizawa H; Tadokoro K; Ito K
J Immunol; 1996 May; 156(10):3980-5. PubMed ID: 8621939
[TBL] [Abstract][Full Text] [Related]
18. Eosinophil leukocyte degranulation in response to serum-opsonized beads: C5a and platelet-activating factor enhance ECP release, with roles for protein kinases A and C.
Egesten A; Malm J
Allergy; 1998 Nov; 53(11):1066-73. PubMed ID: 9860239
[TBL] [Abstract][Full Text] [Related]
19. Effects of physiologic soluble agonists on leukotriene C4 production and degranulation by human eosinophils.
Takafuji S; Tadokoro K; Ito K; Dahinden CA
Int Arch Allergy Immunol; 1995; 108 Suppl 1():36-8. PubMed ID: 7549519
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil elastase and elastase-rich cystic fibrosis sputum degranulate human eosinophils in vitro.
Liu H; Lazarus SC; Caughey GH; Fahy JV
Am J Physiol; 1999 Jan; 276(1):L28-34. PubMed ID: 9887052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
